In the ongoing legal controversy over Merck’s osteoporosis drug Fosamax and the complications experienced by patients who have taken the medication, mainstream media continue to document the developing events concerning the lawsuits over this popular osteoporosis drug, industry analysts noted. In the past decade complaints of cases against the pharmaceutical manufacturer over Fosamax’ side effects have accumulated and in the last few years from 2009, court hearings have been tried and con...